GLAND PHARMA
|
The Current P/E Ratio of GLAND PHARMA is 47.47.
Share Price | ₹2,012.2 | Jul 21,2025 |
Market Cap | ₹33,160.2 Cr | |
Earnings-TTM | ₹698.5 Cr | TTM-Consolidated Results |
Price/Earnings | 47.47x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GLAND PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹33,160.2 Cr] as on Jul 21,2025
(/) Earnings [ ₹698.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 47.47x ]
Thus, for GLAND PHARMA , the investors are currently willing to pay 47.47 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GLAND PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GLAND PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of GLAND PHARMA
PE Ratio Performance Analysis for GLAND PHARMA
- GLAND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 30.20x.
- GLAND PHARMA 's operated at median p/e ratio of 39.27x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/e ratio peaked in Mar2022 at 44.33x.
- GLAND PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does GLAND PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GLAND PHARMA | 698.53 | 47.47 | 33,160.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.96 | 405,872.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 81.06 | 177,609.0 |
CIPLA LTD | 5,291.05 | 22.53 | 119,184.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 62.42 | 119,277.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.43 | 105,116.0 |
MANKIND PHARMA LTD | 2,003.22 | 54.53 | 109,235.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.14 | 97,579.5 |
LUPIN LTD | 3,306.26 | 26.55 | 87,768.6 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.81 | 66,121.4 |
ABBOTT INDIA LTD | 1,414.44 | 51.16 | 72,367.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GLAND PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.43x |
Max industry PE | 81.06x |
Median industry PE | 36.96x |
Average industry PE | 40.10x |
You may also like the below Video Courses